ATHENA study, Table 3 According to a recently published, industry-sponsored study conducted on 12,852 young women, HPV vaccination was found to reduce HPV-16 infections a mere 0.6% in vaccinated women versus unvaccinated women. At the same time, other high-risk (carcinogenic) HPV infections were diagnosed in vaccinated women 2.6% to 6.2% more frequently than in the […]
Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis
By Kumanan Wilson1,2,3,4*, Steven Hawken2, Jeffrey C. Kwong5, Shelley Deeks6, Natasha S. Crowcroft6, Carl Van Walraven1,2,3, Beth K. Potter2,3, Pranesh Chakraborty4,8,Jennifer Keelan7, Michael Pluscauskas4, Doug Manuel2,3,9 Abstract: Background Live vaccines have distinct safety profiles, potentially causing systemic reactions one to 2 weeks after administration. In the province of Ontario, Canada, live MMR vaccine is currently recommended at age 12 months and 18 months. Methods Using […]
Assuring the Quality, Safety, and Efficacy of DNA Vaccines
Robertson JS, Griffiths E Source National Institute for Biological Standards and Control, Herts, UK. Methods Mol Med. 2006;127:363-74. Abstract Scientists in academia whose research is aimed at the development of a novel vaccine or approach to vaccination may not always be fully aware of the regulatory process by which a candidate vaccine becomes a licensed product. It […]
Investigating Viruses in Cells Used to Make Vaccines; and Evaluating the Potential Threat Posed by Transmission of Viruses to Humans
FDA Vaccines Blood & Biologics Principal Investigator: Arifa S. Khan, PhD Office / Division / Lab: OVRR / DVP / LR General Overview The emergence of pathogenic virus infections like influenza and HIV have created an urgent need for new vaccines. Virus-based vaccines are made in living cells (cell substrates). Some manufacturers are investigating the […]
Adventitious Agents and Vaccines
CDC Emerging Infectious Diseases Panel Summary from the 2000 Emerging Infectious Diseases Conference in Atlanta, Georgia Philip R. Krause Food and Drug Administration, Bethesda, Maryland, USA A discussion of adventitious agents and vaccines is pertinent in the context of emerging infectious diseases. Many novel vaccines are produced in animal cell substrates, and emerging infectious diseases […]
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- 9
- Next Page »
